Literature DB >> 31272268

From psychology to physicality: how nerve growth factor transduces early life stress into gastrointestinal motility disorders later in life.

Chi Fung Willis Chow1, Sijia Che1, Hong-Yan Qin2, Hiu Yee Kwan1, Zhao-Xiang Bian1, Hoi Leong Xavier Wong1.   

Abstract

Environmental stressors in early childhood can have a detrimental impact later in life, manifesting in functional gastrointestinal disorders including irritable bowel syndrome (IBS). The phenomenon is also observed in rodents, where neonatal-maternal separation, a model of early life stress, induces phenotypes similar to IBS; however, the underlying mechanisms remain unelucidated. Our recent study provided a mechanism for the pathogenesis in the gut, demonstrating that increased visceral hyperalgesia resulted from the expansion of the intestinal stem cell compartment leading to increased differentiation and proliferation of serotonin (5-hydroxytryptamine/5-HT)-producing enterochromaffin cells. Moreover, it identified nerve growth factor (NGF) as a key mediator of the pathogenesis; surprisingly, it exerts its effect via cross talk with Wnt/β-catenin signaling. This article addresses the roles of NGF in driving IBS and its potential clinical implications, outstanding questions in how psychological stimuli are transduced into physical phenotypes, as well as future directions of our findings. Abbreviations: 5-HT: 5-hydroxytryptamine/serotonin; BDNF: brain-derived neurotrophic factor; CRF: corticotrophin-releasing factor; EC: enterochromaffin; ENS: enteric nervous system; GI: gastrointestinal; GPCR: G-protein-coupled receptor; IBS (-D): irritable bowel syndrome (diarrhea predominant); LRP5/6: low-density lipoprotein receptor-related protein 5/6; MAPK: mitogen-activated protein kinase; NGF: nerve growth factor; NMS: neonatal-maternal separation; PI3K: phosphoinositode3-kinase; PLCγ: phospholipase c, gamma subtype; TrkA: tropomyosin receptor kinase A.

Entities:  

Keywords:  Irritable bowel syndrome; NGF; TrkA; Wnt signaling; intestinal stem cells; serotonin

Year:  2019        PMID: 31272268      PMCID: PMC6681773          DOI: 10.1080/15384101.2019.1637203

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  53 in total

1.  Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation.

Authors:  S A Müller-Lissner; I Fumagalli; K D Bardhan; F Pace; E Pecher; B Nault; P Rüegg
Journal:  Aliment Pharmacol Ther       Date:  2001-10       Impact factor: 8.171

2.  Towards a reduction of rectal pain?

Authors:  D Grundy
Journal:  Neurogastroenterol Motil       Date:  2002-06       Impact factor: 3.598

3.  Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.

Authors:  Sonia Covaceuszach; Antonino Cattaneo; Doriano Lamba
Journal:  Proteins       Date:  2005-02-15

4.  Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface.

Authors:  George L Dale; Paul Friese; Peter Batar; Stephen F Hamilton; Guy L Reed; Kenneth W Jackson; Kenneth J Clemetson; Lorenzo Alberio
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

Review 5.  Nerve growth factor, neural stem cells and Alzheimer's disease.

Authors:  Klaus Heese; Jin Wei Low; Noriko Inoue
Journal:  Neurosignals       Date:  2006-07-04

Review 6.  Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome.

Authors:  P P Humphrey; C Bountra; N Clayton; K Kozlowski
Journal:  Aliment Pharmacol Ther       Date:  1999-05       Impact factor: 8.171

7.  Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers.

Authors:  L A Houghton; J M Foster; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  2000-06       Impact factor: 8.171

8.  Platelet-derived serotonin mediates liver regeneration.

Authors:  Mickael Lesurtel; Rolf Graf; Boris Aleil; Diego J Walther; Yinghua Tian; Wolfram Jochum; Christian Gachet; Michael Bader; Pierre-Alain Clavien
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

Review 9.  Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications.

Authors:  N J Talley
Journal:  Aliment Pharmacol Ther       Date:  1992-06       Impact factor: 8.171

Review 10.  Role of serotonin in the pathophysiology of the irritable bowel syndrome.

Authors:  Michael D Crowell
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

View more
  2 in total

1.  Effect of Reactive EGCs on Intestinal Motility and Enteric Neurons During Endotoxemia.

Authors:  Na Li; Jing Xu; Hui Gao; Yuxin Zhang; Yansong Li; Haiqing Chang; Shuwen Tan; Shuang Li; Qiang Wang
Journal:  J Mol Neurosci       Date:  2022-06-30       Impact factor: 2.866

Review 2.  Potential Roles of Enterochromaffin Cells in Early Life Stress-Induced Irritable Bowel Syndrome.

Authors:  Enfu Tao; Zhenya Zhu; Chenmin Hu; Gao Long; Bo Chen; Rui Guo; Marong Fang; Mizu Jiang
Journal:  Front Cell Neurosci       Date:  2022-03-15       Impact factor: 5.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.